{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "Co-immunoprecipitation and mass spectrometry have identified Caspase-7, an executioner caspase in apoptosis, as a novel interaction partner of ATXN3, particularly with specific isoforms.",
  "functions": [
    {
      "function": "ATXN3 Cleavage in Apoptosis",
      "arrow": "activates",
      "cellular_process": "During apoptosis, executioner caspases, including Caspase-7, proteolytically cleave ATXN3. This cleavage event is not unique to Caspase-7, as studies also implicate other caspases. The process generates a smaller C-terminal fragment of ATXN3 that includes the expanded polyglutamine tract.",
      "effect_description": "The caspase-mediated cleavage of ATXN3, particularly the expanded form, enhances its propensity to aggregate. These fragments are considered more toxic than the full-length protein, contributing to neuronal cell death in Spinocerebellar Ataxia Type 3 (SCA3). Therefore, caspases facilitate the generation of a toxic ATXN3 species.",
      "biological_consequence": [
        "Apoptotic signaling → Activation of executioner caspases (including Caspase-7) → Proteolytic cleavage of ATXN3 → Generation of a C-terminal fragment containing the polyQ tract → Increased aggregation of the ATXN3 fragment → Enhanced cytotoxicity and neurodegeneration."
      ],
      "specific_effects": [
        "Caspase-mediated cleavage of expanded ATXN3 results in increased protein aggregation.",
        "Cleavage produces an approximately 28-kDa fragment containing the polyglutamine repeat.",
        "Inhibition of caspases blocks the proteolytic cleavage of ATXN3."
      ],
      "evidence": [
        {
          "paper_title": "Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3",
          "journal": "Journal of Neurochemistry",
          "year": 2004,
          "relevant_quote": "Using cellular models we now show that the endogenous spinocerebellar ataxia type-3 disease protein, ataxin-3, is proteolyzed in apoptotic paradigms, resulting in the loss of full-length ataxin-3 and the corresponding appearance of an approximately 28-kDa fragment containing the glutamine repeat... Finally, caspase-mediated cleavage of expanded ataxin-3 resulted in increased ataxin-3 aggregation, suggesting a potential role for caspase-mediated proteolysis in spinocerebellar ataxia type-3 pathogenesis.",
          "pmid": "15140190"
        }
      ],
      "pmids": [
        "15140190"
      ],
      "interaction_effect": "cleavage",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "regulates",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The primary mechanism is not ATXN3 activating Caspase-7, but rather Caspase-7 (among other caspases) cleaving ATXN3. This cleavage is a critical event in SCA3 pathogenesis, as it generates a toxic, aggregation-prone C-terminal fragment of ATXN3 containing the polyglutamine tract. While Caspase-7 is an executioner caspase involved in apoptosis, the interaction described in the literature is unidirectional, with ATXN3 as the substrate.",
  "mechanism": "During apoptosis, executioner caspases, including Caspase-7, proteolytically cleave ATXN3. This cleavage event is not unique to Caspase-7, as studies also implicate other caspases. The process generates a smaller C-terminal fragment of ATXN3 that includes the expanded polyglutamine tract.",
  "effect": "The caspase-mediated cleavage of ATXN3, particularly the expanded form, enhances its propensity to aggregate. These fragments are considered more toxic than the full-length protein, contributing to neuronal cell death in Spinocerebellar Ataxia Type 3 (SCA3). Therefore, caspases facilitate the generation of a toxic ATXN3 species.",
  "summary": "ATXN3 inhibits Caspase-7 to modulate atxn3 cleavage in apoptosis, ultimately affecting enhanced cytotoxicity and neurodegeneration.",
  "evidence": [
    {
      "paper_title": "Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3",
      "journal": "Journal of Neurochemistry",
      "year": 2004,
      "relevant_quote": "Using cellular models we now show that the endogenous spinocerebellar ataxia type-3 disease protein, ataxin-3, is proteolyzed in apoptotic paradigms, resulting in the loss of full-length ataxin-3 and the corresponding appearance of an approximately 28-kDa fragment containing the glutamine repeat... Finally, caspase-mediated cleavage of expanded ataxin-3 resulted in increased ataxin-3 aggregation, suggesting a potential role for caspase-mediated proteolysis in spinocerebellar ataxia type-3 pathogenesis."
    }
  ],
  "pathways": [
    {
      "name": "Apoptosis and Proteolytic Cleavage",
      "canonical_name": "Apoptosis",
      "ontology_id": "GO:0006915",
      "ontology_source": "GO",
      "confidence": 0.9
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--regulates-- Caspase-7:",
  "protein_a": "Caspase-7",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-29T18:36:19.030068Z",
  "last_updated": "2025-11-29T18:36:19.030068Z"
}